Clinical Trials Browser

Expanded_access × Neuroblastoma × 1 year × Clear all

Neuroblastoma

NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Available

CNS

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

NCT07223606 2025-11-03

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

No longer available

CNS

Neuroblastoma, Dysbiosis

NCT05064306 2025-08-01

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

No longer available

CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Meningeal Neoplasms, Wilms Tumor, Neuroblastoma, Pinealoma, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Rhabdoid Tumor

NCT06872489 2025-07-23

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

Available

CNSGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Neuroblastoma, Pancreatic Neoplasms, Recurrence

NCT01370330 2025-07-22

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol

Available

CNS

Neoplasms, Neuroblastoma, Recurrence

Clinical Trials

131-I-MIBG Therapy for Refractory Neuroblastoma, Expanded Access Protocol

An Intermediate Expanded Use Trial of DFMO

Fecal Microbiota Transplant for Neuroblastoma in a Single Patient

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Expanded Access Protocol for the Use of SL-28 in the Treatment of Advanced Solid Tumors

131I-Labeled MIBG for Refractory Neuroblastoma: A Compassionate Use Protocol